GPC3-specific CAR-NK-92 cells showed potent antitumor activities only to HCC cells expressing GPC3 molecule, reflecting the safety and specificity of CAR-NK cells [150]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.